Tenx genomics stock price

We are offering shares of our Class A common stock to be sold in the offering. The initial public offering price is�

3 Dec 2019 While the stock saw some volatility post its debut, it currently trades at about $65, a ~65% increase from its IPO price of $39 per share. 17 Mar 2020 Given the most recent momentum in the market in the price movement of OZK stock, some strong opinions on the matter of investing in the� 10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in� In depth view into TXG (10x Genomics) stock including the latest price, news, dividend history, earnings information and financials. 13 Sep 2019 In its first day of trading, 10x Genomics' initial share price of $39 jumped as high as 48% to $57.80 before settling at $52.75 by the close and�

Prev Close 62.27, 52 Wk Low 45.11. Open 62.96, 52 Wk High 108.36. Day Low 61.14, Volume 214,127.00. Day High 63.05, Avg 10D Vol 421,011.00�

Information on stock, financials, earnings, subsidiaries, investors, and executives for 10x Genomics. Use the PitchBook Platform to explore the full profile. According to analysts' consensus price target of $74.17, 10x Genomics has a potential upside of 21.9% from its current price of $60.85. Amount of Analyst� 10x Genomics, Inc. Class A Common Stock (TXG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Prev Close 62.27, 52 Wk Low 45.11. Open 62.96, 52 Wk High 108.36. Day Low 61.14, Volume 214,127.00. Day High 63.05, Avg 10D Vol 421,011.00� View live 10X GENOMICS INC chart to track its stock's price action. Find market predictions, TXG financials and market news. We look at five businesses we believe have potential for the new year. Find out more. Important Documents. There are no documents available for this stock. 10X Genomics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

17 Mar 2020 Given the most recent momentum in the market in the price movement of OZK stock, some strong opinions on the matter of investing in the�

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North � 3 Dec 2019 While the stock saw some volatility post its debut, it currently trades at about $65, a ~65% increase from its IPO price of $39 per share. 17 Mar 2020 Given the most recent momentum in the market in the price movement of OZK stock, some strong opinions on the matter of investing in the� 10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in� In depth view into TXG (10x Genomics) stock including the latest price, news, dividend history, earnings information and financials.

In depth view into TXG (10x Genomics) stock including the latest price, news, dividend history, earnings information and financials.

View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Real time 10x Genomics Inc (TXG) stock price quote, stock graph, news & analysis.

Prev Close 62.27, 52 Wk Low 45.11. Open 62.96, 52 Wk High 108.36. Day Low 61.14, Volume 214,127.00. Day High 63.05, Avg 10D Vol 421,011.00� View live 10X GENOMICS INC chart to track its stock's price action. Find market predictions, TXG financials and market news. We look at five businesses we believe have potential for the new year. Find out more. Important Documents. There are no documents available for this stock.

10X Genomics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. View 10x Genomics Inc. TXG investment & stock information. Get the latest 10x Genomics Inc. TXG detailed stock quotes, stock data, Real-Time ECN, charts,� Learn about TXG with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar �